Isothermal Nucleic Acid Amplification Market

Report Description
Table of Contents

Report Description

The global isothermal nucleic acid amplification market size is estimated to be USD xx billion in 2021 and is expected to witness a CAGR of xx% during the forecast period. Increase in cases of chronic diseases along with growing geriatric population is a key driver for the growth of the global isothermal nucleic acid amplification market. Additionally, growth in the molecular diagnostics market and increasing demand for effective and low-cost effective diagnostics techniques are some of the other drivers propelling the market growth. Nevertheless, lack of knowledge about novel diagnostics technologies and opposition from PCR equipment poses a major challenge for the market are expected to restrain the global market growth.

Global Isothermal Nucleic Acid Amplification Market Size (USD Billion), 2021-2029

Source: Erevna Healthcare

By Product

Based on product, the market is segmented into reagents and instruments. In 2021, the reagents segment accounted for the substantial revenue share with lucrative CAGR during the forecast period. This is attributed to widespread use in hospitals and primary healthcare locations worldwide. Instrument segment projected to grow at a profitable CAGR during the forecast period. This is attributed to the new product launches that are innovative in terms of precision, portability, and speed.

By Technology

Based on technology, the market is categorized into helicase dependent amplification (HDA),nucleic acid sequence-based amplification (NASBA), strand displacement amplification (SDA), loop-mediated isothermal amplification (LAMP), Single primer isothermal amplification (SPIA), nicking enzyme amplification reaction (NEAR), transcription-mediated amplification (TMA), rolling circle amplification (RCP), recombinase polymerase amplification (RPA), smart amplification process version 2 (SMAP2), and others. In 2021, the transcription-mediated amplification (TMA) segment accounted for the substantial revenue share with lucrative CAGR during the forecast period. This is due to the growing population suffering from various chronic diseases has increased demand for low-cost diagnostics worldwide. The helicase dependent amplification (HAD) segment is anticipated to grow at a profitable CAGR during the forecast period, due the launch of new products is driving the market worldwide.

By Application

Based on application, the market is categorized into infectious disease diagnostics, blood screening, cancer, and others. In 2021, the infectious disease diagnostics segment accounted for the substantial revenue share with lucrative CAGR during the forecast period. This is due to the increase in occurrence of diseases such as HIV, hepatitis A & B, and STDs that comprise of chlamydia and gonorrhoea are the factors driving the market worldwide. The blood screening segment is anticipated to grow at a profitable CAGR during the forecast period, due to increase in number of blood transfusions globally, INAAT is majorly used in screening the blood for infectious organisms to prevent epidemics.

By End User

Based on end user, the market is categorized into central and reference labs, hospitals, and others. In 2021, the hospitals segment accounted for the substantial revenue share with lucrative CAGR during the forecast period. This is due to the growth of wireless communication and point of care INAAT instruments used for analysis by providing single-level admittance to diagnostic results throughout the hospital worldwide. The central and reference labs segment is anticipated to grow at a profitable CAGR during the forecast period, due to the increase in number of laboratories along with adoption of new & precise molecular diagnostic methods.

Regional Insights

In 2021, North America accounted for the highest revenue share in the global market and is expected to maintain its dominance during the forecast period. This is attributed to the well-established research structure and rise in research initiatives, growth in initiatives from government, accessibility of technological advanced products in the region. Asia Pacific market is projected to exhibit the fastest CAGR over the forecast period owing to the increase in disposable income in emerging economies, growing government and corporate investment in healthcare sector, rising investments in research centres, and availability of skilled labour forces at economic costs, are the major factors in this region.

North America Isothermal Nucleic Acid Amplification Market Size (2021-2029), USD Billion

Competitor Insights

Some of the key players in the isothermal nucleic acid amplification market are Becton, Dickinson & Company (U.S.); Hologic, Inc. (U.S.); Grifols, S.A. (Spain); EIKEN CHEMICAL CO., LTD. (Japan); Meridian Bioscience (U.S.); Quidel Corporation (U.S.); QIAGEN (Netherlands); bioMérieux SA (France); Tecan Trading AG (Switzerland); and DiaSorin S.p.A. (Italy). The leading players operating in the isothermal nucleic acid amplification industry are adopting various strategies including R&D investments, adaption of advanced techniques, new product launches, mergers & acquisitions, and regional expansions to capture a maximum revenue share.

This exhaustive research report focuses on market size and forecast at global, segmental, regional and country level along with key market trends and dynamics from 2021 to 2029. The isothermal nucleic acid amplification market report is categorized into the following segments and subsegments: